Bone Biologics Corporatio... (BBLG)
NASDAQ: BBLG
· Real-Time Price · USD
2.21
-0.14 (-5.96%)
At close: Aug 15, 2025, 3:10 PM
Bone Biologics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.02M | -1.52M | -941K | -783.73K | -865.97K | -1.55M | -1.92M | -1.77M | -3.71M | 893.46K | -1.22M | -469.3K | -689.5K | -177.74K | -509.3K | -491.9K | -431.75K |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 50.6K | 100.75K | 17.94K | 17.44K | 52.68K | 71.14K | 20.03K | 16.67K | 44.76K | 62.51K | 32.53K | 18.75K | 152.84K | 207.03 | n/a | n/a | 15K |
Other Working Capital | 120.73K | -102.56K | 382.74K | -204.48K | -315.74K | -556.12K | 91.48K | -19.8K | 361.49K | -785.92K | 62.63K | 119.77K | -279.13K | 49.02K | 347.14K | 15K | 15K |
Other Non-Cash Items | 49.25K | -12.96K | 9.97K | -10.79K | -37.31K | -24.76K | -160.65K | -1.27M | 562.92K | -2.18M | n/a | n/a | n/a | -408.46K | 265.55K | 260.02K | 235.82K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 41.72K | 80.42K | 340.93K | -118.79K | -452.81K | -514.51K | -494.89K | -609.9K | 1.75M | -726.21K | 791.46K | 90.49K | -324.12K | 399.14K | -34.02K | -404.1K | 52.94K |
Operating Cash Flow | -926.13K | -1.35M | -572.16K | -895.87K | -1.3M | -2.02M | -2.56M | -3.63M | -1.35M | -1.95M | -395.28K | -360.06K | -860.78K | -186.85K | -277.77K | -635.98K | -127.98K |
Capital Expenditures | 5.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 276.71K | 569.25K | 199.15K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | -3.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 5.02M | 436.00 | n/a | n/a | n/a | n/a | n/a | 4.43M | n/a | n/a | n/a | 6.86M | n/a | n/a | n/a |
Financial Cash Flow | 347.55K | 1.11M | 1.81M | 299.00 | 1.5M | 592K | n/a | 4.45M | n/a | 4.43M | n/a | n/a | n/a | 6.86M | 276.71K | 569.25K | 199.15K |
Net Cash Flow | -578.58K | -241.29K | 1.23M | -895.57K | 201.06K | -1.43M | -2.56M | 819.49K | -1.35M | 2.48M | -395.28K | -360.06K | -860.78K | 6.67M | -1.06K | -66.73K | 71.17K |
Free Cash Flow | -926.12K | -1.35M | -572.16K | -895.87K | -1.3M | -2.02M | -2.56M | -3.63M | -1.35M | -1.95M | -395.28K | -360.06K | -860.78K | -186.85K | -277.77K | -635.98K | -127.98K |